HomePeptides › Kisspeptin-10

Kisspeptin-10

Metastin(45-54), KP-10

Tier 3 · Limited Human Data
Class
KISS1R agonist
Molecular target
KISS1R (GPR54)
Sequence / structure
YNWNSFGLRF-NH2
Evidence tier
Tier 3 — Limited Human Data
Category
Reproductive Axis

Biology & mechanism

The decapeptide fragment of kisspeptin, the master upstream regulator of reproductive endocrinology. Signalling at KISS1R on hypothalamic GnRH neurons triggers GnRH release, and thereby LH and FSH. Loss-of-function mutations in KISS1R cause hypogonadotropic hypogonadism — which is how the pathway's necessity was established. It sits above the entire HPG axis.

What the research actually shows

A genuine and active academic research subject, principally at Imperial College London. Human studies have examined its role in reproductive physiology, hypothalamic amenorrhoea, IVF trigger protocols, and sexual-response neuroimaging. Human data exist, but as physiological investigation — not as an approved therapeutic.

Regulatory status

Not FDA-approved. Investigational; used in academic research under appropriate oversight.

Safety signals

Short-term administration in supervised research settings has been well tolerated. Consequences of unsupervised or repeated administration on HPG axis regulation are not established — this is a master regulator, and perturbing it casually is not a small intervention.

No usage guidance is published here

Forge Bioenergy does not publish dosing, reconstitution, or administration protocols for any peptide. See our editorial policy for why. If you are considering any substance on this page, that conversation belongs with a licensed physician.

References & further reading

Regulatory status changes. This page reflects our reading of public sources as of July 2026 and should be independently verified before it is relied upon.

Important notice Forge Bioenergy publishes scientific reference information only. Nothing on this site is medical advice, a therapeutic claim, or a recommendation to use any substance in humans. Many peptides described here are not approved by the FDA for any use, and several are approved only for narrow indications under prescription. We do not publish dosing, administration, or usage protocols. Consult a licensed physician before making any medical decision.